IDEXX Laboratories, Inc. (IDXX) Tops Q1 EPS by 2c; Increases FY11 EPS Outlook
Tweet
Share
E-mailGet Alerts IDXX Hot Sheet
Price: $545.73 -2.91%
EPS Growth %: +8.8%
Financial Fact:
Gross profit: 246.73M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +8.8%
Financial Fact:
Gross profit: 246.73M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
IDEXX Laboratories, Inc. (NASDAQ: IDXX) reported Q1 EPS of $0.62, $0.02 better than the analyst estimate of $0.60. Revenue for the quarter came in at $292.7 million versus the consensus estimate of $285.61 million.
Increases FY11 EPS outlook from $2.62 - $2.68 to $2.66 - $2.71, versus the consensus of $2.66. Also sees FY11 revenue of $1.205 - $1.215 billion, versus the consensus of $1.19 billion.
Increases FY11 EPS outlook from $2.62 - $2.68 to $2.66 - $2.71, versus the consensus of $2.66. Also sees FY11 revenue of $1.205 - $1.215 billion, versus the consensus of $1.19 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AeroVironment restates quarterly financials, citing $89M goodwill error
- Kroger meets earnings expectations, revenue tops estimates
- Jabil (JBL) Tops Q3 EPS by 8c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
